A Study of SEA-CD40 Given With Other Drugs in Cancers

NCT04993677 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Carcinoma, Non-Small- Cell Lung

Interventions

DRUG: SEA-CD40
DRUG: pembrolizumab (KEYTRUDA®)
DRUG: pemetrexed
DRUG: carboplatin

Sponsor

Seagen Inc.

Collaborators

[object Object]